130 related articles for article (PubMed ID: 37921180)
1. The Radiosensitizing Potentials of Silymarin/Silibinin in Cancer: A Systematic Review.
Gupta J; Turki Jalil A; Al-Hawraa Riyad Muedii Z; Aminov Z; Alsaikhan F; Ramírez-Coronel A; Ramaiah P; Farhood B
Curr Med Chem; 2023 Oct; ():. PubMed ID: 37921180
[TBL] [Abstract][Full Text] [Related]
2. The Radioprotective Potentials of Silymarin/Silibinin Against Radiotherapy- Induced Toxicities: A Systematic Review of Clinical and Experimental Studies.
Latacela GA; Ramaiah P; Patra I; Jalil AT; Gupta R; Madaminov FA; Shaker Shafik S; Al-Gazally ME; Ansari MJ; Kandeel M; Mustafa YF; Farhood B
Curr Med Chem; 2023; 30(33):3775-3797. PubMed ID: 36424777
[TBL] [Abstract][Full Text] [Related]
3. A systematic review of the protective effects of silymarin/silibinin against doxorubicin-induced cardiotoxicity.
Singh M; Kadhim MM; Turki Jalil A; Oudah SK; Aminov Z; Alsaikhan F; Jawhar ZH; Ramírez-Coronel AA; Farhood B
Cancer Cell Int; 2023 May; 23(1):88. PubMed ID: 37165384
[TBL] [Abstract][Full Text] [Related]
4. Silibinin Preferentially Radiosensitizes Prostate Cancer by Inhibiting DNA Repair Signaling.
Nambiar DK; Rajamani P; Deep G; Jain AK; Agarwal R; Singh RP
Mol Cancer Ther; 2015 Dec; 14(12):2722-34. PubMed ID: 26516160
[TBL] [Abstract][Full Text] [Related]
5. The Therapeutic Effect of Silymarin and Silibinin on Depression and Anxiety Disorders and Possible Mechanism in the Brain: A Systematic Review.
Rostamian S; Heidari-Soureshjani S; Sherwin CMT
Cent Nerv Syst Agents Med Chem; 2023; 23(2):86-94. PubMed ID: 37612866
[TBL] [Abstract][Full Text] [Related]
6. Antiproliferative and apoptotic effects of silibinin in rat prostate cancer cells.
Tyagi A; Bhatia N; Condon MS; Bosland MC; Agarwal C; Agarwal R
Prostate; 2002 Nov; 53(3):211-7. PubMed ID: 12386921
[TBL] [Abstract][Full Text] [Related]
7. Silibinin attenuates ionizing radiation-induced pro-angiogenic response and EMT in prostate cancer cells.
Nambiar DK; Rajamani P; Singh RP
Biochem Biophys Res Commun; 2015 Jan; 456(1):262-8. PubMed ID: 25446081
[TBL] [Abstract][Full Text] [Related]
8. Silymarin inhibits growth and causes regression of established skin tumors in SENCAR mice via modulation of mitogen-activated protein kinases and induction of apoptosis.
Singh RP; Tyagi AK; Zhao J; Agarwal R
Carcinogenesis; 2002 Mar; 23(3):499-510. PubMed ID: 11895866
[TBL] [Abstract][Full Text] [Related]
9. The ameliorative effect of silibinin against radiation-induced lung injury: protection of normal tissue without decreasing therapeutic efficacy in lung cancer.
Son Y; Lee HJ; Rho JK; Chung SY; Lee CG; Yang K; Kim SH; Lee M; Shin IS; Kim JS
BMC Pulm Med; 2015 Jul; 15():68. PubMed ID: 26143275
[TBL] [Abstract][Full Text] [Related]
10. Silymarin and its active component silibinin act as novel therapeutic alternatives for salivary gland cancer by targeting the ERK1/2-Bim signaling cascade.
Choi ES; Oh S; Jang B; Yu HJ; Shin JA; Cho NP; Yang IH; Won DH; Kwon HJ; Hong SD; Cho SD
Cell Oncol (Dordr); 2017 Jun; 40(3):235-246. PubMed ID: 28401485
[TBL] [Abstract][Full Text] [Related]
11. Silibinin prevents ultraviolet radiation-caused skin damages in SKH-1 hairless mice via a decrease in thymine dimer positive cells and an up-regulation of p53-p21/Cip1 in epidermis.
Dhanalakshmi S; Mallikarjuna GU; Singh RP; Agarwal R
Carcinogenesis; 2004 Aug; 25(8):1459-65. PubMed ID: 15033902
[TBL] [Abstract][Full Text] [Related]
12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer prevention by silibinin.
Singh RP; Agarwal R
Curr Cancer Drug Targets; 2004 Feb; 4(1):1-11. PubMed ID: 14965263
[TBL] [Abstract][Full Text] [Related]
14. Studies on radiation sensitization efficacy by silymarin in colon carcinoma cells.
Lal M; Gupta D
Discoveries (Craiova); 2016 Apr; 4(1):e56. PubMed ID: 32309577
[TBL] [Abstract][Full Text] [Related]
15. A Systematic Review of the Therapeutic Potential of Resveratrol During Colorectal Cancer Chemotherapy.
Wu XY; Zhai J; Huan XK; Xu WW; Tian J; Farhood B
Mini Rev Med Chem; 2023; 23(10):1137-1152. PubMed ID: 36173048
[TBL] [Abstract][Full Text] [Related]
16. Chemopreventive effects of silymarin and silibinin on N-butyl-N-(4-hydroxybutyl) nitrosamine induced urinary bladder carcinogenesis in male ICR mice.
Tyagi A; Raina K; Singh RP; Gu M; Agarwal C; Harrison G; Glode LM; Agarwal R
Mol Cancer Ther; 2007 Dec; 6(12 Pt 1):3248-55. PubMed ID: 18089718
[TBL] [Abstract][Full Text] [Related]
17. Tissue distribution of silibinin, the major active constituent of silymarin, in mice and its association with enhancement of phase II enzymes: implications in cancer chemoprevention.
Zhao J; Agarwal R
Carcinogenesis; 1999 Nov; 20(11):2101-8. PubMed ID: 10545412
[TBL] [Abstract][Full Text] [Related]
18. A systematic review of the therapeutic effects of resveratrol in combination with 5-fluorouracil during colorectal cancer treatment: with a special focus on the oxidant, apoptotic, and anti-inflammatory activities.
Moutabian H; Majdaeen M; Ghahramani-Asl R; Yadollahi M; Gharepapagh E; Ataei G; Falahatpour Z; Bagheri H; Farhood B
Cancer Cell Int; 2022 Apr; 22(1):142. PubMed ID: 35366874
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of human carcinoma cell growth and DNA synthesis by silibinin, an active constituent of milk thistle: comparison with silymarin.
Bhatia N; Zhao J; Wolf DM; Agarwal R
Cancer Lett; 1999 Dec; 147(1-2):77-84. PubMed ID: 10660092
[TBL] [Abstract][Full Text] [Related]
20. Silymarin and silibinin cause G1 and G2-M cell cycle arrest via distinct circuitries in human prostate cancer PC3 cells: a comparison of flavanone silibinin with flavanolignan mixture silymarin.
Deep G; Singh RP; Agarwal C; Kroll DJ; Agarwal R
Oncogene; 2006 Feb; 25(7):1053-69. PubMed ID: 16205633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
